Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors.

Nature Biotechnology
Elisabet WahlbergJohan Weigelt

Abstract

Inhibitors of poly-ADP-ribose polymerase (PARP) family proteins are currently in clinical trials as cancer therapeutics, yet the specificity of many of these compounds is unknown. Here we evaluated a series of 185 small-molecule inhibitors, including research reagents and compounds being tested clinically, for the ability to bind to the catalytic domains of 13 of the 17 human PARP family members including the tankyrases, TNKS1 and TNKS2. Many of the best-known inhibitors, including TIQ-A, 6(5H)-phenanthridinone, olaparib, ABT-888 and rucaparib, bound to several PARP family members, suggesting that these molecules lack specificity and have promiscuous inhibitory activity. We also determined X-ray crystal structures for five TNKS2 ligand complexes and four PARP14 ligand complexes. In addition to showing that the majority of PARP inhibitors bind multiple targets, these results provide insight into the design of new inhibitors.

References

Apr 18, 1967·Biochimica Et Biophysica Acta·T SugimuraY Kawamura
Mar 1, 1980·The Biochemical Journal·M R Purnell, W J Whish
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·A RufG E Schulz
Nov 20, 1998·Science·S SmithT de Lange
Jan 8, 2004·Journal of the National Cancer Institute·Christopher R CalabreseNicola J Curtin
Jul 27, 2004·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Jean-Christophe AméGilbert de Murcia
May 3, 2005·Nature Reviews. Drug Discovery·Prakash Jagtap, Csaba Szabó
Feb 4, 2006·The Journal of Biological Chemistry·Han-Yi E ChouSheng-Chung Lee
Oct 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Masoud VedadiAled M Edwards
Nov 7, 2006·Neuroscience·T M Kauppinen, R A Swanson
Nov 6, 2007·Frontiers in Bioscience : a Journal and Virtual Library·Paul O Hassa, Michael O Hottiger
Dec 14, 2007·Proceedings of the National Academy of Sciences of the United States of America·Oleg FedorovStefan Knapp
Mar 11, 2008·Nature Biotechnology·Markus Ringnér
Mar 21, 2008·Trends in Molecular Medicine·José YélamosFrançoise Dantzer
Apr 26, 2008·Journal of Molecular Biology·Lari LehtiöJohan Weigelt
Oct 15, 2008·Molecular Cell·Henning KleineBernhard Lüscher
Dec 17, 2008·Cancer Research·Alan Ashworth
Apr 10, 2009·Journal of Medicinal Chemistry·Lari LehtiöTobias Karlberg
Jun 26, 2009·The New England Journal of Medicine·Peter C FongJohann S de Bono
Sep 12, 2009·Expert Opinion on Therapeutic Patents·Gianluca PapeoAlessia Montagnoli
Sep 18, 2009·Nature·Shih-Min A HuangFeng Cong
Jan 29, 2010·Trends in Biochemical Sciences·Michael O HottigerFriedrich Koch-Nolte
Feb 16, 2010·Nature Chemical Biology·Stephen V Frye
Apr 23, 2010·Molecular Neurobiology·Robert Piotr StrosznajderJoanna Benigna Strosznajder
Jun 23, 2010·Journal of Medicinal Chemistry·Tobias KarlbergHerwig Schüler
Sep 9, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ruth Plummer
Oct 15, 2010·BMC Evolutionary Biology·Matteo CitarelliRebecca S Lamb
Feb 11, 2011·Nature·Aled M EdwardsFrank H Yu
Mar 2, 2011·The American Journal of Pathology·Xueqing Ba, Nisha Jain Garg

❮ Previous
Next ❯

Citations

Jan 9, 2014·Bioorganic & Medicinal Chemistry·Raffaella CincinelliSabrina Dallavalle
Sep 24, 2013·Journal of Molecular Graphics & Modelling·Albert A AntolinAntonio Macchiarulo
Jan 30, 2013·Molecular Aspects of Medicine·Carles CantóPeter Bai
Mar 6, 2013·Molecular Aspects of Medicine·Tobias KarlbergHerwig Schüler
Mar 12, 2013·Journal of Medicinal Chemistry·Andrew VoronkovStefan Krauss
May 16, 2013·Journal of Medicinal Chemistry·E Andreas LarssonPär Nordlund
Aug 22, 2013·Journal of Medicinal Chemistry·Ianire MartinArturo Muga
Oct 15, 2013·Journal of Medicinal Chemistry·Mohit NarwalLari Lehtiö
Mar 9, 2012·Nature Biotechnology·Philip Jones
Feb 21, 2013·Nature Communications·Greg M ThurberRalph Weissleder
Dec 1, 2012·Nature Reviews. Drug Discovery·Jenna L RiffellAlan Ashworth
Jun 21, 2012·Nature Reviews. Molecular Cell Biology·Bryan A Gibson, W Lee Kraus
Jun 5, 2012·The Journal of Biological Chemistry·Tobias KarlbergHerwig Schüler
Nov 3, 2012·Cancer Research·Junko MuraiYves Pommier
Sep 29, 2012·Current Pharmaceutical Design·Andrey Voronkov, Stefan Krauss
Oct 24, 2012·Future Medicinal Chemistry·Federico Gago
Sep 1, 2012·CNS Oncology·Ross Carruthers, Anthony J Chalmers
Jun 6, 2014·Nature Reviews. Cancer·Sejal Vyas, Paul Chang
Feb 11, 2014·Nucleic Acids Research·Karolin LégerMichael O Hottiger
Jun 18, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Roberta FeliciAlberto Chiarugi
Sep 10, 2014·Cell Reports·Kristin A KrukenbergTimothy J Mitchison
Oct 22, 2014·PeerJ·Laura Lafon-HughesSilvia H Fernández Villamil
Oct 30, 2014·The New England Journal of Medicine·Donal P McLornanGhulam J Mufti
Dec 25, 2013·Biochimica Et Biophysica Acta·Magdolna SzántóPéter Bai
Jul 28, 2015·Expert Opinion on Therapeutic Targets·Michael O Hottiger
Dec 22, 2015·The American Journal of Pathology·Neus Martínez-BoschJosé Yélamos
Sep 19, 2012·Current Opinion in Structural Biology·Markus Hassler, Andreas G Ladurner
Mar 19, 2016·Redox Biology·Andrew J O SmithI Michael Wormstone
Jun 20, 2015·Molecular Cell·Casey M DanielsAnthony K L Leung
Oct 13, 2015·Journal of Medicinal Chemistry·Oscar AubiJarl Underhaug
Mar 16, 2013·Immunology·Maria Manuela RosadoClaudio Pioli
Apr 18, 2013·The FEBS Journal·Emanuele S ScarpaMaria Di Girolamo
Apr 23, 2013·The FEBS Journal·Torun EkbladAntonio Macchiarulo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.